Pharmacological pain management in cancer patients

被引:0
作者
Muetherig, Anke [1 ,2 ]
Scheffler, Gesine [3 ]
Schuler, Ulrich S. S. [1 ,2 ]
机构
[1] Univ Klinikum Carl Gustav Carus Dresden, Palliativ Zentrum, Fetscherstr 74, D-01307 Dresden, Germany
[2] Univ Klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, D-01307 Dresden, Germany
[3] Univ Klinikum Carl Gustav Carus Dresden, Klin Apotheke, Dresden, Germany
来源
ONKOLOGIE | 2023年 / 29卷 / 08期
关键词
Cancer pain; Analgesics; opioid; Morphine; Acetaminophen; Cannabinoids; ANALGESIC LADDER; MORPHINE; VALIDATION; METHADONE; EFFICACY; OPIOIDS; TRIAL;
D O I
10.1007/s00761-023-01394-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pharmacological pain therapy in cancer patients is based on guideline recommendations, which, however, do not fully coincide in all aspects due to varying weighting of evidence. The present article discusses current issues including the decreasing significance of the World Health Organization (WHO) analgesic ladder, with its distinction between step 2 and 3 being increasingly questioned. Risks of nonopioid analgesics such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), particularly in older populations, are discussed. Paracetamol may potentially reduce the effectiveness of immunotherapies. Aspects of administering analgesics via a feeding tube are considered. Recommendations for the treatment of episodic pain, transitioning between different opioids, and some relevant interactions are also discussed.
引用
收藏
页码:727 / 736
页数:10
相关论文
共 32 条
[1]  
[Anonymous], 2018, WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
[2]  
AWMF, 2020, ERW S3 LEITL PALL PA
[3]   Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis [J].
Balanaser, Marielle ;
Carley, Meg ;
Baron, Ralf ;
Finnerup, Nanna B. ;
Moore, R. Andrew ;
Rowbotham, Michael C. ;
Chaparro, Luis E. ;
Gilron, Ian .
PAIN, 2023, 164 (02) :230-251
[4]   Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain [J].
Bandieri, Elena ;
Romero, Marilena ;
Ripamonti, Carla Ida ;
Artioli, Fabrizio ;
Sichetti, Daniela ;
Fanizza, Caterina ;
Santini, Daniele ;
Cavanna, Luigi ;
Melotti, Barbara ;
Conte, Pier Franco ;
Roila, Fausto ;
Cascinu, Stefano ;
Bruera, Eduardo ;
Tognoni, Gianni ;
Luppi, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) :436-U99
[5]   Impact of acetaminophen on the efficacy of immunotherapy in cancer patients [J].
Bessede, A. ;
Marabelle, A. ;
Guegan, J. P. ;
Danlos, F. X. ;
Cousin, S. ;
Peyraud, F. ;
Chaput, N. ;
Spalato, M. ;
Roubaud, G. ;
Cabart, M. ;
Khettab, M. ;
Chaibi, A. ;
Rey, C. ;
Nafia, I ;
Mahon, F. X. ;
Soria, J. C. ;
Italiano, A. .
ANNALS OF ONCOLOGY, 2022, 33 (09) :909-915
[6]   The impact of communication on adherence in pain management [J].
Butow, Phyllis ;
Sharpe, Louise .
PAIN, 2013, 154 :S101-S107
[7]   Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC [J].
Caraceni, Augusto ;
Hanks, Geoff Rey ;
Kaasa, Stein ;
Bennett, Michael I. ;
Brunelli, Cinzia ;
Cherny, Nathan ;
Dale, Ola ;
De Conno, Franco ;
Fallon, Marie ;
Hanna, Magdi ;
Haugen, Dagny Faksvag ;
Juhl, Gitte ;
King, Samuel ;
Klepstad, Pal ;
Laugsand, Eivor A. ;
Maltoni, Marco ;
Mercadante, Sebastiano ;
Nabal, Maria ;
Pigni, Alessandra ;
Radbruch, Lukas ;
Reid, Colette ;
Sjogren, Per ;
Stone, Patrick C. ;
Tassinari, Davide ;
Zeppetella, Giovambattista .
LANCET ONCOLOGY, 2012, 13 (02) :E58-E68
[8]   Practice review: Evidence-based and effective management of pain in patients with advanced cancer [J].
Chapman, Emma J. ;
Edwards, Zoe ;
Boland, Jason W. ;
Maddocks, Matthew ;
Fettes, Lucy ;
Malia, Catherine ;
Mulvey, Matthew R. ;
Bennett, Michael I. .
PALLIATIVE MEDICINE, 2020, 34 (04) :444-453
[9]   Misappropriation of the 1986 WHO analgesic ladder: the pitfalls of labelling opioids as weak or strong [J].
Crush, Jos ;
Levy, Nicholas ;
Knaggs, Roger D. ;
Lobo, Dileep N. .
BRITISH JOURNAL OF ANAESTHESIA, 2022, 129 (02) :137-142
[10]   A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids [J].
Currow, David C. ;
Clark, Katherine ;
Louw, Sandra ;
Fazekas, Belinda ;
Greene, Aine ;
Sanderson, Christine R. .
EUROPEAN JOURNAL OF PAIN, 2020, 24 (05) :983-991